Propranolol Hydrochloride Injection shortage
Current 2 presentations · 2 manufacturers · first FDA posting 2023-10-31 · last update 2026-10-15
Manufacturers: Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Delay in shipping of the drug; Shortage of an active ingredient
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Next release: November 2026. Check wholesalers for inventory. | Posted 10/31/2023 Updated 10/15/2026 |
| Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 10/31/2023 Updated 10/14/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)